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Abstract
Background: Infectious bursal disease (IBD) results in economic loss due to mortality, reduction in production
efficiency and increasing the usage of antibiotics. This study was carried out to investigate the modulatory roles of
dietary n-3 polyunsaturated fatty acids (PUFA) enrichment in immune response and performance of IBD challenged
broiler chickens.
Methods: A total of 300 day old male broiler chicks were assigned to four dietary n-3 PUFA ascending levels as
the treatment groups (T1: 0.5; T2: 8.0; T3: 11.5; T4: 16.5) using combinations of tuna oil and sunflower oil. All diets
were isocaloric and isonitrogenous. On day 28, all birds were challenged with IBD virus. Antibody titer, cytokine
production, bursa lesion pre and post-challenge and lymphoid organ weight were recorded.
Results: On d 42 the highest body weight was observed in the T2 and T3 and the lowest in T4 chickens. Feed
conversion ratio of the T2 broilers was significantly better than the other groups. Although productive parameters
were not responded to the dietary n-3 PUFA in a dose-dependent manner, spleen weight, IBD and Newcastle
disease antibody titers and IL-2 and IFN-g concentrations were constantly elevated by n-3 PUFA enrichment.
Conclusions: Dietary n-3 PUFA enrichment may improve the immune response and IBD resistance, but the
optimum performance does not coincide with the optimum immune response. It seems that dietary n-3 PUFA
modulates the broiler chicken performance and immune response in a dose-dependent manner. Thus, a moderate
level of dietary n-3 PUFA enrichment may help to put together the efficiency of performance and relative immune
response enhancement in broiler chickens.
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Background
There has been fast growth in the global interest to the
effects of diet on various aspects of immune function.
Typically, different research groups have assessed differ-
ent nutrients, each using different animal models. Most
of these models focus on selected aspects of immune
function without assessing the other functions. It is
therefore always difficult to understand the broader mod-
ulating influence for instance on the productive para-
meters. In modern poultry industry, however, within
commonly used feed there is an oversupply of n-6 poly-
unsaturated fatty acids (PUFA) and an undersupply of n-
3 PUFA, causing an imbalance in the corn-soybean diet.
Consumption of n-3 PUFA, resulted in incorporation of
these fatty acids into lipid membrane of all tissues,
including cells of the immune system [1,2]. Long chain
n-3 PUFA showed to improve the immune response and
reduce inflammation in different species such as chicken,
mice and fish [3-5].
On the other hand, infectious bursal disease (IBD) is one
of the most important chicken diseases that have emerged
in the last 30 years. IBD viral infection suppresses the
immune system in young chickens, making birds sensitive
to other diseases [6-8]. In poultry production, it is very
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important to improve immunity for prevention of infec-
tious diseases. Minimizing immunosuppression and its
impact is an important factor for success in the broiler
production. In vivo and in vitro studies have shown that
the target cell in IBD is IgM-bearing B lymphocyte. The
acute lytic phase of the virus is associated with a reduction
in circulating IgM+ cells [8-11]. Immunoglobulin M is the
major class of antibody found in serum, in the primary
immune response (first encounter of antigen). Supplemen-
tation of dietary n-3 PUFA has shown to increase IgM
level, suggesting an immuno-stimulating property of n-3
PUFA. immunoglobulins production by b cells and inter-
feron-g (IFN-g) is facilitated by interlukin-2 (IL-2). This
elevation is more pronounced in docosahexaenoic acid
(DHA) rich diet than eicosapentaenoic acid (EPA) rich
diet [12]. Another study showed that IgG and IgE response
increased to ovalbumin in rats fed a high fish oil diet [13].
It has also demonstrated that n-3 PUFA from fish oil have
an antiviral effect in mice [14,15]. The n-3 PUFA in fish
oil can affect immune cell activation in both the innate
and specific immune systems in different species [4,16-18].
Therefore, diet enrichment with n-3 PUFA consider as an
alternative to enhance immune response and disease resis-
tance. Among common sources of fish oil used in biome-
dical research, tuna oil has an interesting balance of n-3
PUFA and it contains much more DHA than EPA [19,20].
As for the chicken nutrition and immune response, to
date, there is no report on immunomodulatory effects of
dietary n-3 PUFA under IBD challenge in broiler chick-
ens. Therefore, this study aimed to investigate the influ-
ence of dietary n-3 PUFA enrichment on immune
response and performance of IBD challenged broiler
chickens.
Results
Nutrient Composition and Fatty Acids Analysis
Nutrient composition is shown in Table 1 and fatty acid
profile of the experimental diets and oils are shown in
Table 2 and 3. Linoleic acid (C18:2 n-6) was the main n-6
PUFA in the diets and it was decreased as the fish oil
increased. An opposite trend was observed for EPA and
DHA contents while a-linolenic acid (C18:3n-3)
remained unchanged. The resulting DHA content of the
diets were 0, 5.6, 8.17 and 11.93 for T1 to T4, respec-
tively. Influence of treatment diets on plasma fatty acid
composition on d 28 and 42 are shown in Table 4 and 5.
It was clearly indicated that the incorporation of fish oil
into diet significantly increased the n-3 PUFA in plasma.
On d 28 and 42 the highest plasma n-3 PUFA was
observed in the T4 birds diet while the highest plasma n-
6 PUFA was measured in T2 birds. The same results
were observed in breast muscle on d 42 (Table 6).
Performance Parameters
There were no effects of dietary n-3 PUFA enrichment
on Body weight, feed intake and FCR on d 21 (Table 7).
Table 1 Nutrient composition of experimental diets (%).
1-21 days 22-42 days
Ingredients T1† T2 T3 T4 T1 T2 T3 T4
Corn 44.91 45.61 45.75 45.86 49.90 51.45 51.49 51.54
Soybean meal 43.85 43.73 43.59 43.48 38.67 38.43 38.39 38.34
Palm oil 6.58 0.00 0.00 0.00 7.31 0.00 0.00 0.00
Sunflower oil 0.00 3.50 2.00 0.50 0.00 3.50 2.00 0.50
Tuna oil 0.00 2.50 4.00 5.50 0.00 2.50 4.00 5.50
Di calcium phosphate 1.91 1.91 1.91 1.91 1.77 1.77 1.77 1.77
Limestone 1.20 1.20 1.20 1.20 1.06 1.06 1.06 1.06
Salt 0.44 0.44 0.44 0.44 0.31 0.31 0.31 0.31
Vitamin premix 0.30 0.30 0.30 0.30 0.30 0.30 0.30 0.30
Mineral premix 0.30 0.30 0.30 0.30 0.30 0.30 0.30 0.30
DL-Methionine 0.25 0.25 0.25 0.25 0.23 0.23 0.23 0.23
Lysine 0.26 0.26 0.26 0.26 0.15 0.15 0.15 0.15
Calculated composition (%)
Crude protein 22.00 22.00 22.00 22.00 20.50 20.50 20.50 20.50
ME (Kcal/kg) 3080 3080 3080 3080 3150 3150 3150 3150
Available phosphorus 0.45 0.45 0.45 0.45 0.42 0.42 0.42 0.42
Calcium 1.00 1.00 1.00 1.00 0.90 0.90 0.90 0.90
Methionine 0.55 0.55 0.55 0.55 0.50 0.50 0.50 0.50
Lysine 1.20 1.20 1.20 1.20 1.00 1.00 1.00 1.00
Na 0.20 0.20 0.20 0.20 0.15 0.15 0.15 0.15
† Dietary n-3 PUFA level of 0.5 (T1), 8.0 (T2), 11.5 (T3), 16.5% (T4).
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However, on d 42, birds in T4 group that received the
highest n-3 PUFA showed the lowest body weight (P <
0.05). A superior FCR was recorded for the birds of
group T2. Feed intake was not affected by the dietary
n-3 PUFA enrichment throughout the study (P > 0.05).
Lymphoid Organ Weight
Bursa of Fabricius weight was not influenced by n-3
PUFA enrichment (P > 0.05) (Table 8). Spleen weight
7 d after challenge was increased steadily by dietary
treatment from T1 to T4 where the lowest was recorded
in T1 and the highest in T4. There were no significant
differences in spleen weight pre-challenge or 14 days
after challenge.
Histopathological Lesion Score
The Effect of dietary n-3 PUFA enrichment on lesion
score of bursa in IBD challenged broiler chickens is pre-
sented in Table 9. Dietary treatment was not affected
the bursa of Fabricius tissue pathologically throughout
the study as measured by lesion scoring (P > 0.05).
Serology
The effect of dietary n-3 PUFA enrichment on serum
antibody titer (log10) in broilers vaccinated against ND
and challenged with IBD virus is shown in Figure 1.
Serum IBD and ND antibody titers were not influenced
by treatments pre-challenge on d 28 and 14 days after
challenge. However, there was a significant alteration in
both antibody titers seven days after IBD challenge.
Interestingly, this alteration was along with the ascend-
ing trend of n-3 PUFA enrichment. The lowest and
highest IBD and ND antibody titers were in T1 and T4
chickens, respectively.
Table 3 Fatty acid composition of dietary treatments (%).
Fatty acids Palm oil Tuna oil Sunflower oil
14:0 1 3.1 nd
16:0 45 22.8 7
18:0 4 6.7 5
18:1 n-9 40 17.7 19
18:2 n-6 10 1.6 68
18:3 n-3 - 2.3 1
20:5 n-3 - 4.6 -
22:6 n-3 - 18.3 -
PV† (mEq/Kg) 0.9 1.4 1.1
†PV = Peroxide value. nd = not detected.
Table 2 Fatty acid composition of dietary treatments
(percentage of total fatty acids).
Treatments
Fatty acids T1† T2 T3 T4
14:0 0.8 0.9 1.8 2.5
15:0 - - - 0.7
15:1 - - - -
16:0 32.7 15.7 17.3 19.5
16:1 - 1.4 2.4 3.3
17:0 - 0.9 1.0 1.4
17:1 - - 0.6 0.8
18:0 4.1 4.9 4.9 5.6
18:1 39.2 27.8 26.9 23.3
18:2 n-6 21.9 38.8 31.9 24.8
18:3 n-3 - 0.5 0.6 0.6
20:4 n-6 - 0.6 0.7 1.1
20:5 n-3 - 1.5 2.3 3.2
22:5 n-3 - - 0.6 0.8
22:6 n-3 - 5.6 8.2 11.9
SFA 38.2 23.2 25.9 30.0
UFA 61.8 76.8 74.1 69.9
MUFA 39.5 29.5 29.9 27.5
PUFA n-3 0.5 8.0 11.5 16.5
PUFA n-6 21.9 39.4 32.6 25.9
UFA: SFA 1.6 3.5 2.9 2.3
PUFA: SFA 0.6 2.1 1.7 1.4
n-6: n-3 51.7 5.1 2.8 1.6
† Dietary n-3 PUFA level of 0.5 (T1), 8.0 (T2), 11.5 (T3), 16.5% (T4).
Table 4 Influence of dietary treatments on plasma fatty
acid composition at 28 days of age in broiler chickens
(%).
Treatments
Fatty acids T1† T2 T3 T4
14:0 0.46 ± 0.03b 0.49 ± 0.01b 0.67 ± 0.1a 0.84 ± 0.1a
15:0 1.17 ± 0.2 1.37 ± 0.1 1.01 ± 0.2 1.23 ± 0.2
16:0 21.41 ± 0.5b 20.84 ± 0.8b 22.37 ± 0.6ab 23.99 ± 0.4a
16:1 1.66 ± 0.7 0.61 ± 0.1 1.02 ± 0.1 1.14 ± 0.1
17:0 0.82 ± 0.2 0.95 ± 0.2 0.97 ± 0.2 0.84 ± 0.1
18:0 12.78 ± 0.2 14.09 ± 0.5 12.71 ± 0.3 13.10 ± 0.6
18:1 n-9 29.15 ± 1.5a 15.36 ± 1.3b 15.53 ± 0.7b 14.67 ± 0.9b
18:2 n-6 24.70 ± 0.7b 30.06 ± 0.9a 26.41 ± 1.3a 21.19 ± 1.2c
18:3 n-3 0.64 ± 0.04 0.48 ± 0.03 0.65 ± 0.1 0.69 ± 0.1
20:4 n-6 4.12 ± 0.9ab 4.61 ± 0.5a 3.57 ± 0.3ab 2.95 ± 0.3b
20:5 n-3 - 1.71 ± 0.1c 3.21 ± 0.2b 3.95 ± 0.2a
22:6 n-3 - 6.92 ± 0.1c 9.33 ± 0.4b 12.52 ± 0.6a
SFA 38.68 ± 0.7b 39.26 ± 0.5ab 39.10 ± 0.7b 41.69 ± 0.5a
UFA 61.32 ± 0.7a 60.74 ± 0.5a 60.90 ± 0.7a 58.31 ± 0.5b
MUFA 31.86 ± 2.2a 16.95 ± 1.3b 17.72 ± 0.8b 17.01 ± 1.0b
PUFA n-3 0.64 ± 0.04d 9.12 ± 0.2c 13.20 ± 0.5b 17.16 ± 0.8a
PUFA n-6 28.82 ± 1.6b 34.67 ± 1.4a 29.98 ± 1.2b 24.14 ± 1.3b
UFA: SFA 1.59 ± 0.1 1.55 ± 0.03 1.56 ± 0.05 1.40 ± 0.03
PUFA: SFA 0.76 ± 0.03b 1.12 ± 0.1a 1.11 ± 0.04a 0.99 ± 0.04a
n-6: n-3 45.26 ± 1.9a 3.80 ± 0.1b 2.29 ± 0.2c 1.43 ± 0.1d
† Dietary n-3 PUFA level of 0.5 (T1), 8.0 (T2), 11.5 (T3), 16.5% (T4). n = 8 birds/
treatment.
a-d Means with different superscripts within a row differ significantly (P <
0.05).
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Cytokine Production
The IL-2 and IFN-g levels increased along with the n-3
PUFA enrichment pre and 2 days post-challenge from
T2 group to T4 (Table 10). However, there was no dif-
ference in IFN-g level 2 days post-challenge and IL-2
and IFN-g 7 days post-challenge. Surprisingly, both IL-2
and IFN-g were significantly higher in T1 than T2
before challenge.
Discussion
Fats and oils are usually provided for chicken as dietary
energy source to enhance the productivity and fulfill the
high energy demand of fast growing broilers. Among the
different fats and oils, the high n-6 PUFA sources are
cheaper and easier available. Incorporation of these
sources resulted in high concentration of the n-6 PUFA
in the meat or egg product, and less EPA, (20:5 n-3), doc-
osapentaenioc (DPA 22:5 n-3) and DHA (22:6 n-3) [21].
On the other hand, dietary n-3 PUFA enrichment and
lowering n-6: n-3 PUFA ratio alters the fatty acid profile
of meat toward long chain PUFA [22,23]. In agreement,
current study results showed that the total n-3 PUFA,
EPA and DHA of plasma and breast muscle significantly
increased along with ascending n-3 PUFA inclusion from
T1 to T4. There was a relatively high level of arachidonic
acid (AA, 20:4 n-6) to linoleic acid (LA, 18:2 n-6) in
plasma of T1 on day 28 and 42. This phenomenon can
be explained by the absence of linolenic acid (LNA, 18:3
n-3) in the diet of this group, while the other groups have
LNA of 0.5, 0.6 and 0.6% (Table 2). Simopoulos [16] indi-
cated that there is a competition between LA and LNA
for conversion to the long-chain PUFA because they
share the same enzymes and LNA is the preferred sub-
strate. Moreover, there was no detectable DHA in plasma
of T1 as their representative diet was also free of EPA
and DHA and their precursor LNA.
Dietary n-3 PUFA enrichment also increased body
weight and improved FCR as measured in T2 and T3 at
42 days of age. This may be due to the superior digestibil-
ity of unsaturated fatty acid compared to saturated type
[24-27]. Newman [21] showed the modulatory effects of
dietary n-3 and n-6 PUFA FCR in avian metabolism
through the modulation of lipid deposition and oxidation.
However, the enhancement was not observed in highest n-
3 PUFA (T4) group, leading to the postulation that effect
of n-3 PUFA enrichment is a dose-dependent response.
Hulan [28] reported that isoenergetic and isonitrogenous
diets enriched with redfish meal and redfish oil led to
lower body weights than the control diet. They attributed
this result to lower palatability and higher calcium levels,
Table 6 Influence of dietary treatments on breast muscle
fatty acid composition at 42 days of age in broiler
chickens (%).
Treatments
Fatty acids T1† T2 T3 T4
14:0 0.66 ± 0.04c 0.79 ± 0.03bc 0.90 ± 0.05ab 1.07 ± 0.06a
15:0 0.45 ± 0.08 0.42 ± 0.04 0.53 ± 0.09 0.56 ± 0.06
16:0 23.50 ± 0.51 21.82 ± 0.46 22.03 ± 0.35 21.64 ± 1.48
16:1 2.81 ± 0.45a 1.29 ± 0.14c 1.63 ± 0.26bc 2.51 ± 0.28ab
17:0 0.37 ± 0.03 0.60 ± 0.10 0.66 ± 0.07 0.71 ± 0.10
18:0 10.01 ± 0.51 11.81 ± 0.36 11.71 ± 0.68 11.92 ± 0.89
18:1 n-9 35.11 ± 1.00a 21.26 ± 0.78b 20.96 ± 1.39b 19.53 ± 1.57b
18:2 n-6 16.47 ± 0.41b 20.57 ± 0.90a 16.24 ± 1.06b 14.77 ± 1.49b
18:3 n-3 0.45 ± 0.03 0.42 ± 0.03 0.42 ± 0.08 0.59 ± 0.08
20:4 n-6 5.67 ± 0.70ab 6.17 ± 0.41a 5.11 ± 0.77ab 3.95 ± 0.61b
20:5 n-3 - 1.20 ± 0.16b 2.24 ± 0.37a 2.83 ± 0.14a
22:6 n-3 - 8.26 ± 0.74b 13.13 ± 0.82a 14.84 ± 1.18a
SFA 35.99 ± 0.52 37.04 ± 0.90 37.27 ± 1.01 37.32 ± 1.10
UFA 64.01 ± 0.52 62.96 ± 0.90 62.73 ± 1.01 62.68 ± 1.10
MUFA 39.80 ± 1.23a 24.91 ± 0.73b 24.66 ± 1.51b 24.04 ± 1.39b
PUFA n-3 0.45 ± 0.03c 9.88 ± 0.82b 15.79 ± 0.96a 18.26 ± 1.19a
PUFA n-6 23.76 ± 0.96b 28.17 ± 0.81a 22.28 ± 0.86b 20.38 ± 1.67b
UFA: SFA 1.78 ± 0.04 1.71 ± 0.07 1.69 ± 0.08 1.69 ± 0.08
PUFA: SFA 0.67 ± 0.02b 1.03 ± 0.05a 1.02 ± 0.03a 1.05 ± 0.09a
n-6: n-3 54.29 ± 4.79a 2.96 ± 0.29b 1.45 ± 0.15c 1.14 ± 0.12c
† Dietary n-3 PUFA level of 0.5 (T1), 8.0 (T2), 11.5 (T3), 16.5% (T4). n = 8 birds/
treatment.
a-d Means with different superscripts within a row differ significantly (P <
0.05).
Table 5 Influence of dietary treatments on plasma fatty
acid composition at 42 days of age in broiler chickens (%).
Treatments
Fatty acids T1† T2 T3 T4
14:0 0.48 ± 0.1b 0.61 ± 0.04ab 0.77 ± 0.1a 0.89 ± 0.1a
15:0 0.83 ± 0.1b 0.62 ± 0.2b 0.84 ± 0.2b 1.50 ± 0.1a
16:0 21.71 ± 0.7b 23.80 ± 0.4ab 24.94 ± 1.0a 25.45 ± 0.4a
16:1 3.24 ± 0.5a 1.54 ± 0.4b 1.30 ± 0.3b 1.47 ± 0.1b
17:0 0.56 ± 0.1 1.02 ± 0.2 1.04 ± 0.3 1.10 ± 0.2
18:0 15.21 ± 0.7a 13.87 ± 0.4ab 12.45 ± 0.6b 12.31 ± 0.6b
18:1 n-9 32.28 ± 1.2a 19.51 ± 1.1ab 15.54 ± 0.5c 17.90 ± 1.0b
18:2 n-6 19.24 ± 1.1bc 23.41 ± 1.8a 21.66 ± 1.3ab 15.92 ± 1.0c
18:3 n-3 0.42 ± 0.1bc 0.48 ± 0.03bc 0.58 ± 0.1ab 0.66 ± 0.1a
20:4 n-6 3.81 ± 0.2a 2.93 ± 0.6ab 2.72 ± 0.5ab 1.94 ± 0.1b
20:5 n-3 - 2.32 ± 0.1c 3.75 ± 0.3b 5.18 ± 0.7a
22:6 n-3 - 7.63 ± 0.9b 11.07 ± 0.7a 13.03 ± 0.6a
SFA 40.06 ± 1.0 41.03 ± 0.8 41.99 ± 1.1 42.66 ± 0.3
UFA 59.94 ± 1.0 58.97 ± 0.8 58.01 ± 1.1 57.34 ± 0.3
MUFA 36.47 ± 1.7a 22.21 ± 1.bb 18.23 ± 0.5b 20.61 ± 1.0b
PUFA n-3 0.42 ± 0.1d 10.43 ± 0.9c 15.39 ± 0.8b 18.87 ± 0.7a
PUFA n-6 23.05 ± 1.2a 26.33 ± 1.5a 24.39 ± 1.5a 17.86 ± 1.0b
UFA: SFA 1.51 ± 0.1 1.44 ± 0.1 1.39 ± 0.1 1.34 ± 0.0
PUFA: SFA 0.59 ± 0.03b 0.90 ± 0.07a 0.96 ± 0.1a 0.86 ± 0.03a
n-6: n-3 62.29 ± 11.1a 2.58 ± 0.2b 1.61 ± 0.2c 0.95 ± 0.1c
† Dietary n-3 PUFA level of 0.5 (T1), 8.0 (T2), 11.5 (T3), 16.5% (T4). n = 8 birds/
treatment.
a-d Means with different superscripts within a row differ significantly (P < 0.05).
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although no palatability problem as a result of n-3 PUFA
supplementation in the diet was found in the present
study. Evidently, significant differences due to dietary
treatment are absent from the feed intake throughout the
experimental period. In any case, in accordance Korver
[29] demonstrated that low levels of dietary fish oil were
more efficient than high levels in improving broiler growth
rate and FCR, even when the birds were undergoing an
inflammatory response.
Immune tissue development can in some cases reflect
immune system response and functionality. In the current
study, there was no affect of dietary treatment on the
bursa of Fabricius weight and lesion score, but spleen
weight increased as the level of n-3 PUFA in diet increased
7 days post-challenge. Some other studies reported that
feeding PUFA to chickens [30] and mice [31] results in
increased spleen weights. In the study of Wang [30], the
author used single-comb White Leghorn layers fed sun-
flower oil, animal oil, linseed oil, or fish oil at 5% (wt/wt).
The results demonstrated that chicks fed the 3 PUFA-rich
diets had significantly higher weights of the thymus,
spleen, and bursa compared with those of chicks fed the
diet with animal oil. In our study, the spleen enlargement
due to dietary n-3 PUFA enrichment accompanied with
the same trends of IBD and ND antibody responses,
boosting immune system and enhance spleen task.
Increasing of the IBD and ND titer can be explained by
the fact that IL-2 is able to facilitate production of immu-
noglobulins made by b cells. Anti-sheep red blood cell
antibody responses of rats fed 17 g fish oil were signifi-
cantly higher than corn oil fed rats [32]. The b cell popula-
tion is not affected by dietary fat in non-infected mice, but
the fish oil enrichment results in the highest percentage of
b cells in infected mice [33]. Furthermore, fortifying the
diet with n-3 PUFA from fish oil (5%) significantly
increased serum IgG concentration and IgM+ B cells in
chicken [30]. Immunoglobulin M as the major antibody in
the primary immune response reduces in circulating sys-
tem during the acute lytic phase of the IBD virus [8,10,11].
The present study provides the evidences for immuno-sti-
mulating properties of dietary n-3 PUFA in IBD infected
chicken through antibody body response improvement
and probably IgM-bearing B lymphocyte proliferation.
One of the interesting results of the current study is the
ascending elevation of IL-2 and IFN-g concentrations along
with the n-3 PUFA enrichment from T2 to T4. Cytokine
production plays an important role in mounting a com-
plete and full immune response of both the innate and spe-
cific systems. These cytokines are produced by T helper
lymphocytes (Th1) and activate macrophages, NK cells,
and cytotoxic T lymphocytes and are the principal effectors
of cell-mediated immunity. Interactions with bacteria,
viruses, and fungi tend to induce Th1 activity. Because Th1
cytokines activate monocytes and macrophages, these cyto-
kines may be regarded as pro-inflammatory. Interlukin-2
can enhance interferon production [34,35]. Interferon-g is
a cytokine that is critical for innate and adaptive immunity
against viral and intracellular bacterial infections. A close
relationship exists between cytokine synthesis and n-3 fatty
acids. It is possible that eicosanoid production derived
from n-3 PUFA might stimulate the production of IL-2
and IFN-g [36,37]. At present, the mechanisms by which
dietary n-3 PUFA modulate cytokine production is not
clarified. However, the possible mechanism might be the
Table 8 Effect of n-3 PUFA enrichment on relative lymphoid organ weight in IBD challenged broiler chickens.
Spleen Bursa of Fabricius








T1† 0.10 ± 0.004 0.06 ± 0.003b 0.08 ± 0.008 0.18 ± 0.005 0.11 ± 0.009 0.04 ± 0.004
T2 0.10 ± 0.010 0.09 ± 0.009ab 0.08 ± 0.010 0.23 ± 0.007 0.10 ± 0.010 0.05 ± 0.005
T3 0.11 ± 0.008 0.09 ± 0.008ab 0.09 ± 0.011 0.22 ± 0.02 0.11 ± 0.010 0.05 ± 0.002
T4 0.09 ± 0.009 0.12 ± 0.008a 0.09 ± 0.010 0.22 ± 0.02 0.10 ± 0.009 0.04 ± 0.004
† Dietary n-3 PUFA level of 0.5 (T1), 8.0 (T2), 11.5 (T3), 16.5% (T4). n = 8 birds/treatment.
a-b Means within a column with different letters differ significantly (P < 0.05).
Table 7 Effect of n-3 PUFA enrichment on performance and mortality of IBD challenged broiler chickens.
1-21 days 1-42 days
Treatments Body weight (g) Feed intake (g/bird) FCR Body weight (g) Feed intake (g/bird) FCR Mortality (%)
T1† 798 ± 10 1397 ± 25 1.75 ± 0.02 2215 ± 30ab 4740 ± 87 2.05 ± 0.03a 7 ± 2
T2 788 ± 11 1366 ± 33 1.75 ± 0.03 2276 ± 28a 4568 ± 74 1.94 ± 0.03b 7 ± 2
T3 801 ± 10 1335 ± 9 1.72 ± 0.03 2251 ± 28a 4689 ± 66 1.97 ± 0.03ab 7 ± 2
T4 783 ± 9 1403 ± 16 1.78 ± 0.03 2147 ± 29b 4570 ± 40 2.05 ± 0.03a 8 ± 2
† Dietary n-3 PUFA level of 0.5 (T1), 8.0 (T2), 11.5 (T3), 16.5% (T4). n = 75 birds/treatment.
a-b Means within a column with different letters differ significantly (P < 0.05).
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decreased production of metabolites of n-6 PUFA, such as
PGE2 and changes in phospholipids composition of
immune cell membranes. Some studies suggested the
PGE2 which is derived from arachidonic acid and n-6
PUFA as the possible candidate for inhibition of T cell pro-
liferation, Th1 cell, IL-2 and IFN-g production [38-40]. The
PGE2 primes human naive T cells in a dose-dependent
fashion for production of high levels of IL-4, IL-10, and IL-
13 and very low levels of IL-2 and IFN-g [41]. Furthermore,
some researchers noted that high levels of dietary fish oil
apparently have different immunomodulatory effects than
lower levels [42]. It is reported that n-3 PUFA decreases
production of PGE2 [43] due to a competition between n-3
PUFA and n-6 PUFA for incorporation into the cell mem-
brane phospholipids. This finding is in contrast with the
result of dietary fish oil supplementation in human [4,36]
and rat [44]. However, these findings are consistent with
the effects of dietary supplementation in non-human pri-
mates [45] in human [43,46] and mice [47]. A possible
explanation for the contrast in results between the present
study and other reported studies may referred to the intake
levels EPA and DHA, source and type of oil and the con-
centration of dietary fat. There is another highlight in the
current study results on the IL-2 and IFN-g concentration
where high level of these cytokines observed in T1 chick-
ens that received the lowest amount of n-3 PUFA. There is
no clear explanation for the phenomenon, but it may
speculated that this observation is contributed to the dose-
response characteristic of the immune functions to n-3
PUFA levels [41,42] or low level of linoleic acid in T1 com-
pare to the other groups. Linoleic acid reported to inhibit
the proliferation of rodent and human lymphocytes and
decrease the production of IL-2 by mitogenstimulated rat
and human lymphocytes [5,48,49], suggesting that it is
potentially immunosuppressive.
Conclusions
In conclusion, dietary n-3 PUFA enrichment may improve
the immune response and IBD resistance, but the opti-
mum performance does not coincide with the optimum
immune response. It seems that dietary n-3 PUFA modu-
lates the broiler chicken performance and immune
response to IBD challenge in a dose-dependent manner.
Thus, a moderate level of dietary n-3 PUFA enrichment
may help to put together the efficiency of performance
and relative immune response enhancement in broiler
chickens.
Methods
Birds and Housing Environment
A total of three hundred day-old male broiler chicks
(Cobb 500) were obtained from a local hatchery. The
chicks were wing-banded, individually weighed, and
housed. The birds were raised on conventional deep litter
system in an open sided house with cyclic temperatures
(minimum, 24°C; maximum, 34°C). The relative humidity
was between 60 to 80%. The area of each pen was 2 m2.
Feed and water were provided ad libitium and lighting
was continuous. The chicks were vaccinated against
Newcastle disease (Animal Health, Fort Dodge, Iowa,
USA) on day 7 (intraocular) and on day 21(intranasal).
Experimental Design
Experimental procedure was approved by the ACUC Ani-
mal Care and Use Committee of the University of Putra
Malaysia. Commencing from day one, five replicate pens of
15 chicks each were assigned to one of the four dietary
treatments, giving a total of 20 pens. There were four diet-
ary n-3 PUFA ascending levels as the treatment groups
(T1: 0.5; T2: 8.0; T3: 11.5; T4: 16.5) achieved using a com-
binations of tuna oil, sunflower oil and palm oil in feed for-
mulation (Table 1). All diets were isocaloric and
isonitrogenous. The diets (mash form) were formulated to
meet or exceed requirements by the NRC [50] for broiler
chickens. The diets were prepared weekly and kept at 4°C
to prevent rancidity and oxidation. No antimicrobial, antic-
occidial drugs or feed enzymes were included in the diets.
Performance Parameters
All chickens were individually weighed weekly. Feed
intake per group was recorded weekly and feed conver-
sion ratios (FCR) were calculated. Mortality was
recorded daily in each subgroup.
Challenge Protocol
On day 28 of age, all birds were challenged by an oral
route with a commercial live IBD vaccine (V877 strain,
Malaysian Vaccines and Pharmaceuticals Sdn. Bhd). The
strain was characterized as an intermediate classical strain.
Each bird was inoculated with a dose of 104.0 EID50 IBD
virus into the lumen of the crop by oral gavage [51].
Lymphoid Organ Weight and Histopathological
Examination
Prior to IBD challenge (d 28), 7 and 14 d post-challenge,
eight birds from each group were chosen randomly and
Table 9 Effect of n-3 PUFA enrichment on
histopathological changes (lesion score) of bursa in IBD
challenged broiler chickens.




T1† 0.5 ± 0.2 2.0 ± 0.4 3.8 ± 0.2
T2 0.3 ± 0.2 3.2 ± 0.5 3.0 ± 0.7
T3 0.3 ± 0.2 3.0 ± 0.3 3.7 ± 0.2
T4 0.6 ± 0.2 2.2 ± 0.3 3.5 ± 0.3
† Dietary n-3 PUFA level of 0.5 (T1), 8.0 (T2), 11.5 (T3), 16.5% (T4).
n = 8 birds/treatment.
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killed by cervical dislocation, the bursas of Fabricius and
spleen were removed and their weight recorded and pre-
sented as relative to body weight [52]. The bursas of
Fabricius were then fixed in 10% buffered formalin, pro-
cessed for histology, and lesions were scored from 0 to

































































Figure 1 Effects of n-3 PUFA enrichment on serum IBD (A) and ND (B) antibody titers (log10) in IBD challenged broiler chickens. Dietary
n-3 PUFA levels were as follows: 0.5 (T1), 8.0 (T2), 11.5 (T3), 16.5% (T4). Measurements were on 28 days of age (Pre-challenge) and 7 and 14 days
after the IBD challenge. a-b Means with no common letter within sampling time subgroup differ P < 0.05. n = 10 birds/treatment.
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Muskett [53]. The breast muscle samples also were col-
lected and frozen quickly in liquid nitrogen, and stored
at -70°C until further analysis for fatty acids profile.
Fatty acid Extraction and Identification
The total fatty acids were extracted from diets, oils and
breast muscle samples using chloroform: methanol 2:1
(v/v) based on the Folch [54] modified by Rajion [55]
with an antioxidant to prevent the oxidation during
sample preparation. The experimental diets and plasma
were homogenized in 40 ml chloroform: methanol (2:1
v/v) using an Ultra-Turrax T5 FU homogenizer (IKA
Analysentechnik GmBH, Germany). Transmethylation of
the extracted fat to fatty acid methyl esters (FAME)
were carried out using KOH in methanol and 14%
methanolic boron triflouride (BF3) (Sigma Chemical Co.
St. Louis, Missouri, USA) according to methods in
AOAC [56]. The methyl esters were quantified by gas
chromatography (Agilent 7890N) using a 30 m × 0.25
mm ID (0.20 μm film thickness) Supelco SP-2330 capil-
lary column (Supelco, Inc., Bellefonte, PA, USA). One
microliter of FAME was injected by an auto sampler
into the chromatograph, equipped with a split/splitless
injector and a flame ionization detector (FID). The
injector temperature was programmed at 250°C and the
detector temperature was 300°C. The column tempera-
ture program initiated runs at 100°C, for 2 min, warmed
to 170°C at 10°C/min, held for 2 min, warmed to 220°C
at 7.5°C/min, and then held for 20 min to facilitate opti-
mal separation. All results of fatty acid were presented
as the percentage of total fatty acids. All peaks were
quantified using fatty acid standards (Supelco 18919,
fatty acid methyl ester mixture, USA).
Serology
Prior to IBD challenge (d 28), 7 and 14 d post-challenge,
ten birds from each group were chosen at random, and
blood samples were collected from the brachial vein.
Serum was separated by centrifugation (3000 g, 15 min-
utes) and antibody titre against ND and IBD were mea-
sured using commercially available ELISA kits (Bio-check
B.V., Gouda, Holland) according to manufacturer’s
instructions. The absorbance of controls and samples
were read at 405 nm using an ELISA reader (Bio-Tek
Instruments Inc. ELX 800; Winooski, VT).
Cytokine Measurement
The serum levels of IL-2 and IFN-g were determined
using a chicken specific ELISA kits (Cusabio Biotech,
USA). The procedure was following the procedure
recommended by the manufacturer.
Statistical Analysis
A completely randomized design (CRD) with five repli-
cates was employed for this study. Statistical analyses
were conducted using one-way ANOVA general linear
models. Means were separated by Duncan’s multiple
range tests. Antibody titers of IBD and ND were loga-
rithmically transformed prior to analysis to achieve
homogeneity of variance and were expressed as log10.
The IL-2 and IFN-g data were normalized using square
root transformation prior to analysis. Mortality data
were subjected to chi-square analysis. The results were
expressed as mean ± SEM. Statistical significance was
considered at P < 0.05.
List of Abbreviations
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